#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12904	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2094	607.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	695	C	677	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23458	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3720	625.9	0	.	n	.	0	T695C	SNP	695	695	T	1166	1166	C	762	C,T,A	740,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23458	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3720	625.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2442	2442	C	712	C,T	692,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23458	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3720	625.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2516	2516	A	699	A,C	686,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23458	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3720	625.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3068	3068	C	714	C	696	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23458	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3720	625.9	0	HET	.	.	.	G1337A	.	1337	1337	G	1808	1808	G	716	G,A	553,149	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	22	blaTEM	861	470	100.0	blaTEM.l15.c30.ctg.1	470	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	22	blaTEM	861	154	100.0	blaTEM.l15.c30.ctg.2	341	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1670	folP	855	855	100.0	folP.l15.c4.ctg.1	1635	101.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1124	1126	AGC	153;153;155	A;G;C	150;149;152	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4830	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3372	142.0	1	SNP	p	S91F	1	.	.	271	273	TTC	612	614	TTC	189;191;190	T;T;C	181;182;180	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4830	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3372	142.0	1	SNP	p	D95G	1	.	.	283	285	GGC	624	626	GGC	181;177;177	G;G;C	172;171;168	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4830	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3372	142.0	1	SNP	p	G95N	0	.	.	283	285	GGC	624	626	GGC	181;177;177	G;G;C	172;171;168	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1612	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1437	111.5	1	SNP	p	G45D	0	.	.	133	135	GGC	569	571	GGC	198;199;199	G;G;C	190;196;193	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	840	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	983	84.6	0	.	n	.	0	A197.	DEL	197	197	A	597	597	A	192	A	188	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4414	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3146	139.1	1	SNP	p	D86N	0	.	.	256	258	GAC	628	630	GAC	159;161;160	G;A,C;C	152;150,1;154	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4414	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3146	139.1	1	SNP	p	R87I	0	.	.	259	261	CGT	631	633	CGT	159;158;159	C;G;T	154;150;148	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4414	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3146	139.1	1	SNP	p	S87R	1	.	.	259	261	CGT	631	633	CGT	159;158;159	C;G;T	154;150;148	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4414	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3146	139.1	1	SNP	p	R87W	0	.	.	259	261	CGT	631	633	CGT	159;158;159	C;G;T	154;150;148	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4414	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3146	139.1	1	SNP	p	S88P	0	.	.	262	264	TCC	634	636	TCC	158;159;158	T;C;C	150;153;151	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3492	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2629	131.7	0	.	p	.	0	H468Y	NONSYN	1402	1404	CAC	1729	1731	TAC	181;183;179	T;A;C	169;158;171	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3492	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2629	131.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1555	1557	GGC	168;163;162	G;G;C	163;157;160	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1327	1329	GCA	166;165;162	G;C;A	162;160;158	penA.21.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1330	1332	ATC	164;165;161	A;T;C	161;159;156	penA.21.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1342	1344	GTG	168;168;169	G;T;G	166;162;165	penA.21.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1342	1344	GTG	168;168;169	G;T;G	166;162;165	penA.21.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1846	1848	ACC	162;165;165	A;C,A;C,T	153;156,1;153,1	penA.21.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1900	1902	GTG	149;147;148	G;T,G;G	141;124,7;141	penA.21.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1900	1902	GTG	149;147;148	G;T,G;G	141;124,7;141	penA.21.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2023	2025	GGT	128;129;126	G,T;G;T	120,1;123;119	penA.21.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2032	2034	GGC	118;117;116	G;G;C	115;114;111	penA.21.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.21.001	penA.21.001	1	1	27	3324	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2483	132.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2050	2052	CCG	109;110;113	C;C;G	95;102;102	penA.21.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4804	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3222	147.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1668	1670	CCG	168;169;167	C;C;G	155;164;159	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2180	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1744	123.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	552	552	C	162	C,G	151,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	692	694	AAG	187;191;191	A;A;G	181;184;183	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	D121G	NONSYN	361	363	GAC	695	697	GGC	193;192;192	G;G;C,A	184;184;180,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	E212D	NONSYN	634	636	GAA	968	970	GAT	194;199;203	G,C;A;T,A	183,1;185;187,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	H213G	NONSYN	637	639	CAT	971	973	GGT	202;202;200	G;G;T	190;192;181	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	977	979	GCT	201;202;201	G;C;T	193;190;191	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	I218M	NONSYN	652	654	ATC	986	988	ATG	194;192;190	A;T;G	187;185;180	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1103	1105	ACG	187;186;184	A;C;G	185;184;182	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1109	1111	GTT	188;185;184	G;T;T	186;179;183	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2310	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1696	134.7	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1223	1225	AAC	169;169;169	A;A;C	167;165;162	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8562	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4954	171.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	996	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1102	89.8	1	SNP	p	V57M	1	.	.	169	171	ATG	574	576	ATG	189;189;187	A;T;G	188;188;185	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
